Japan Policy Panel Stalls On Drug Patents

Law360, New York (November 1, 2004, 12:00 AM EST) -- A policy panel that is preparing a planned overhaul of Japan’s intellectual property laws has yet to decide on the patentability of new uses for existing drugs and medical devices, according to local media.

At issue is whether "methods for having existing drugs express new effects" through new combinations of multiple drugs and new methods of administration should be eligible for patent protection.

Under the current patent regime in Japan, the discovery of new therapeutic or preventive effects by new drug combinations and adjustment of administration...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.